Pignochino et al. indicated sorafenib induces cytotoxicity and apoptosis and reduces protein expression of pERK and MCL-1, and inhibits protein secretion of VEGF and MMP-2 in osteosarcoma [12]. This evidence concerns the gene VEGFA and osteosarcoma.